Status:

COMPLETED

One-Year Outcomes After Conventional vs Accelerated Epi-Off Corneal Cross-Linking in Progressive Keratoconus (Observational Cohort)

Lead Sponsor:

Clinical Hospital Centre Zagreb

Conditions:

Keratoconus

Eligibility:

All Genders

Brief Summary

Prospective, observational (consecutive eligible eyes) continuation of a previously published 6-month cohort from the same center, extending follow-up to 12 months. Patients with progressive keratocon...

Detailed Description

This prospective, single-center observational cohort extends the follow-up of a previously reported 6-month series from the same center to a 12-month horizon. The study population comprises consecutiv...

Eligibility Criteria

Inclusion

  • Progressive keratoconus documented on serial Scheimpflug tomography within the prior 12 months (ABCD/K-metrics and/or pachymetry).
  • Clear corneal axis (no visually significant scarring).
  • Corneal thickness 370 μm or more

Exclusion

  • No central corneal scars, prior chemical burns, severe corneal infection, or ocular surface disease.
  • No pregnancy and lactation during treatment.

Key Trial Info

Start Date :

May 9 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 12 2023

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT07194538

Start Date

May 9 2021

End Date

January 12 2023

Last Update

October 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Centre Zagreb

Zagreb, Croatia, 10 000